Aigen Investment Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,522
| Closed | -$375K | – | 1066 |
|
|
2025
Q1 | $375K | Buy |
+9,522
| New | +$375K | 0.06% | 423 |
|
|
2024
Q3 | – | Sell |
-18,464
| Closed | -$328K | – | 1010 |
|
|
2024
Q2 | $328K | Buy |
18,464
+2,292
| +14% | +$40.8K | 0.06% | 447 |
|
|
2024
Q1 | $246K | Buy |
+16,172
| New | +$246K | 0.05% | 492 |
|
|
2023
Q4 | – | Sell |
-94,748
| Closed | -$792K | – | 1081 |
|
|
2023
Q3 | $792K | Buy |
94,748
+83,783
| +764% | +$700K | 0.15% | 219 |
|
|
2023
Q2 | $272K | Sell |
10,965
-4,772
| -30% | -$119K | 0.04% | 522 |
|
|
2023
Q1 | $237K | Buy |
+15,737
| New | +$237K | 0.03% | 488 |
|
|
2021
Q1 | – | Sell |
-16,246
| Closed | -$845K | – | 878 |
|
|
2020
Q4 | $845K | Buy |
+16,246
| New | +$845K | 0.11% | 245 |
|